🇺🇸 FDA
Patent

US 8721620

Swallowable drug delivery device and methods of drug delivery

granted A61KA61K31/155A61K38/17

Quick answer

US patent 8721620 (Swallowable drug delivery device and methods of drug delivery) held by Rani Therapeutics, LLC expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/155, A61K38/17, A61K38/22, A61K38/2235